← FDA Drug Approvals (Drugs@FDA)

SILDENAFIL CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2020-05-29

Drug application

FDA Application #

ANDA211534

Application type

Abbreviated New Drug Application (Generic)

Brand name

SILDENAFIL CITRATE

Generic name

SILDENAFIL

Active ingredients

SILDENAFIL CITRATE

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Actavis Pharma, Inc.

First approval

2020-05-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown